ARCHIVES

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

This article is from The Cancer Letter archive.

Vol. 34 No. 34 | September 19, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach

September 11, 2009

Major Changes Being Considered By NCI For FCRA

April 14, 1978

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983